PERTH, Australia – Australia's Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) and Biopacific Partners have launched a new program that will work with small Australian biotechs to better prepare them for partnering with big pharma.
PERTH, Australia – Another battle is brewing over Australia's Research and Development Tax Incentive in the lead up to the annual Federal Budget that is released in early May.
PERTH, Australia – Another battle is brewing over Australia's Research and Development Tax Incentive in the lead up to the annual Federal Budget that is released in early May.
PERTH, Australia – A new class of synthetic antibiotics with broad-spectrum activity is being developed by Sydney-based Recce Pharmaceuticals Ltd. that could solve the problem of antibiotic resistance.
PERTH, Australia – Sydney-based Kazia Therapeutics Ltd. has begun a U.S. phase II trial in glioblastoma with lead candidate GDC-0084, in-licensed from Roche Holding AG unit Genentech.
PERTH, Australia – A new class of synthetic antibiotics with broad-spectrum activity is being developed by Sydney-based Recce Pharmaceuticals Ltd. that could solve the problem of antibiotic resistance.
